NEWS ABOUT US EXPERIENCE STRATEGY TEAM PORTFOLIO CONTACT US

 

NEWS

2014 | 2013 | 2011 | 2010 | 2009

 

 

 


Portola Pharmaceuticals
December 10, 2012 - Portola Initiates Phase 2 Study of PRT4445, Universal Antidote for Factor Xa Inhibitor Anticoagulants
Press Release | Company News


Pathwork Diagnostics
November 5, 2012 - Pathwork Diagnostics Appoints Lee McCracken as CEO
Press Release | Company News


Portola Pharmaceuticals
November 1, 2012 - Portola, Bristol-Myers Squibb And Pfizer Sign Clinical Collaboration Agreement To Study ELIQUIS® And Portola’s Universal Factor Xa Inhibitor Antidote PRT4445
Press Release | Company News


Kythera
October 11, 2012 - KYTHERA Biopharmaceuticals announces pricing of initial public offering
Article | Company News


NinePoint
October, 2 2012 - NinePoint Medical selected to 2012 “Fierce 15” List of Innovative Companies; Also Appoints Chief Financial Officer and Vice President of Sales
Press Release | Company News


DFine
September 18, 2012 - DFINE Announces Full U.S. Commercial Release of STAR Tumor Ablation System
Press Release | Company News


Alvine
September 5, 2012 - - Alvine’s ALV003 Receives Fast Track Designation From FDA for Potential Treatment of Celiac Disease
Press Release | Company News


DFine
September 5, 2012 - Medical Device Veteran, Bill McMullen, Joins DFine as Director of Clinical Development, RadioFrequency Ablation
Press Release | Company News


Kythera
September 4, 2012 - KYTHERA Biopharmaceuticals Completes Enrollment in Pivotal U.S. and Canadian Phase III Clinical Trials to Evaluate ATX-101 for Reduction of Submental Fat
Press Release | Company News


Lux Biosciences
July 9, 2012 - Lux Biosciences Completes Enrollment in Phase 3 Study of Non-infectious Uveitis Drug Candidate Luveniq
Press Release | Company News


Topica Pharmaceuticals
June 27, 2012 - Topica Initiates Phase 2b/3 Study of Luliconazole in Patients with Onychomycosis of the Toenails
Press Release | Company News


Portola Pharmaceuticals
June 15, 2012 - Portola Advances PRT4445, Factor Xa Inhibitor Antidote, into Clinical Development
Press Release | Company News


NinePoint
June 6, 2012 - NinePoint Medical Receives European CE Mark Approval And ISO Certification
Press Release | Company News


Kythera
June 5, 2012 - KYTHERA Biopharmaceuticals Receives $33.3M in Payments from Bayer
Press Release | Company News


SentreHeart
June 4, 2012 - SentreHeart secures $26 million in series C financing for commercialization
Press Release | Company News


Kythera
May 31, 2012 - KYTHERA Biopharmaceuticals Receives Notice of Allowance from U.S. Patent Office for Composition Claims Covering ATX-101 Active Ingredient
Press Release | Company News


Baxano
May 22, 2012 - Baxano Completes Enrollment in Lumbar Spinal Stenosis Study
Press Release | Company News


Kythera
May 17, 2012 - Kythera Biopharmaceuticals Files Registration Statement for Proposed Initial Public Offering
Press Release | Company News


NinePoint
May 11, 2012 - NinePoint Medical to Unveil NvisionVLE Imaging System at Digestive Diseases Week 2012
Press Release | Company News


Azelon
May 2, 2012 - Azelon Pharmaceuticals Announces Completion of Phase 2 Trial Studying Nasal Spray Formulation of Teriparatide in Development for Osteoporosis.
Press Release | Company News


Kythera
April 25, 2012 - Kythera Biopharmaceuticals Announces Positive Results From Two Pivotal European Phase III Trials of ATX-101 For Reduction of Submental Fat
Press Release | Company News


Portola Pharmaceuticals
March 30, 2012 - Portola Initiates Global Pivotal Phase 3 Study of Factor Xa Inhibitor Betrixaban
Press Release | Company News


Baxano
March 6, 2012 - Baxano, Inc. Receives CE Mark for iO-Flex System
Press Release | Company News


Kythera
March 5, 2012 - Kythera Biopharmaceuticals Announces Initiation of Pivotal U.S. Phase III Clinical Trials to Evaluate ATX-101 For Reduction of Submental Fat
Press Release | Company News


Satori
February 23, 2012 - Satori Pharma Raises $15M From Insiders For Alzheimer's Therapy
Press Release | Company News


NinePoint
February 22, 2012 - NinePoint Medical Initiates Clinical Trial of Nvision VLE Imaging System; Program On Track for Commercial Launch in 2013
Press Release | Company News


Baxano
February 7, 2012 - Health Canada Issues Medical Device License to Baxano for iO-Flex System
Press Release | Company News


NinePoint Medical
January 5, 2012 - NinePoint Medical Receives FDA 510(k) Clearance for Nvision VLE Imaging System
Press Release | Company News


Amicus Therapeutics
January 6, 2012 - Amicus Therapeutics Announces Positive Preliminary Results From Ongoing Phase 2 Chaperone-Enzyme Replacement Therapy (ERT) Study for Fabry Disease
Press Release | Company News

 

News Archives